Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis

Multiple Sclerosis Journal

Impact Factor: 4.1 / 5-Year Impact Factor: 4.9

Journal Homepage Submission guidelines

Restricted access

Letter

First published online April, 2018

Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis

, , [...], and

Volume 24, Issue 4

https://doi.org/10.1177/1352458517719152

Abstract

Get full access to this article

View all access options for this article.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Restricted access

ECTRIMS 2015 Committees

Restricted access

Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: No

Restricted access

Interferon beta treatment in multiple sclerosis: the European clinical trials

Restricted access

A New Synthetic Protease Inhibitor,E-3123,Prevents Lysosomal and Mitochondrial Fragility in Rat Caerulein-Induced Pancreatitis